BR8702151A - Processo de controle do peso molecular de oxidos polialquenicos - Google Patents

Processo de controle do peso molecular de oxidos polialquenicos

Info

Publication number
BR8702151A
BR8702151A BR8702151A BR8702151A BR8702151A BR 8702151 A BR8702151 A BR 8702151A BR 8702151 A BR8702151 A BR 8702151A BR 8702151 A BR8702151 A BR 8702151A BR 8702151 A BR8702151 A BR 8702151A
Authority
BR
Brazil
Prior art keywords
polyalkenylic
oxides
molecular weight
control process
weight control
Prior art date
Application number
BR8702151A
Other languages
English (en)
Inventor
Walter Thomas Reichle
Original Assignee
Union Carbide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Carbide Corp filed Critical Union Carbide Corp
Publication of BR8702151A publication Critical patent/BR8702151A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2642—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds characterised by the catalyst used
    • C08G65/269—Mixed catalyst systems, i.e. containing more than one reactive component or catalysts formed in-situ
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/06—Cyclic ethers having no atoms other than carbon and hydrogen outside the ring
    • C08G65/08—Saturated oxiranes
    • C08G65/10—Saturated oxiranes characterised by the catalysts used
    • C08G65/12—Saturated oxiranes characterised by the catalysts used containing organo-metallic compounds or metal hydrides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polyethers (AREA)
BR8702151A 1986-05-02 1987-04-30 Processo de controle do peso molecular de oxidos polialquenicos BR8702151A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/858,914 US4667013A (en) 1986-05-02 1986-05-02 Process for alkylene oxide polymerization

Publications (1)

Publication Number Publication Date
BR8702151A true BR8702151A (pt) 1988-02-09

Family

ID=25329489

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8702151A BR8702151A (pt) 1986-05-02 1987-04-30 Processo de controle do peso molecular de oxidos polialquenicos

Country Status (6)

Country Link
US (1) US4667013A (pt)
EP (1) EP0243969A3 (pt)
JP (1) JPS62273227A (pt)
AU (1) AU7227387A (pt)
BR (1) BR8702151A (pt)
CA (1) CA1279435C (pt)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051610A1 (fr) * 1998-04-03 1999-10-14 Nippon Shokubai Co., Ltd. Procede servant a produire des particules organometalliques fines et catalyseur de polymerisation
WO2000077072A1 (en) * 1999-06-11 2000-12-21 The Procter & Gamble Company Soluble polyfunctional initiators for lactone ring-opening polymerization
CN1234769C (zh) 2000-09-12 2006-01-04 联合碳化化学及塑料技术公司 含有烯化氧共聚物的聚合物复合材料
AU2003243172A1 (en) * 2002-04-29 2003-11-17 Alza Corporation Reduced formate poly(alkylene oxides) with secondary amines for reducing impurity formation
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
PL1842533T3 (pl) * 2003-08-06 2013-08-30 Gruenenthal Gmbh Postać aplikacyjna zabezpieczona przed nadużyciem
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004020220A1 (de) * 2004-04-22 2005-11-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032103A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
CA2583375C (en) 2004-09-02 2013-01-15 Yale University Regulation of oncogenes by micrornas
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8354384B2 (en) * 2005-06-23 2013-01-15 Yale University Anti-aging micrornas
US8658608B2 (en) * 2005-11-23 2014-02-25 Yale University Modified triple-helix forming oligonucleotides for targeted mutagenesis
US7645616B2 (en) * 2006-10-20 2010-01-12 The University Of Hong Kong Use of lipocalin-2 as a diagnostic marker and therapeutic target
JP2010515464A (ja) * 2007-01-11 2010-05-13 イエール・ユニバーシテイ Ｈｉｖ細胞表面受容体の標的化不活性化のための組成物および方法
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
US20100111943A1 (en) * 2007-03-22 2010-05-06 Medical College Of Georgia Research Institute, Inc Compositions and methods for inhibiting cancer metastasis
BRPI0906467C1 (pt) * 2008-01-25 2021-05-25 Gruenenthal Gmbh forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
WO2009111375A2 (en) * 2008-03-01 2009-09-11 Abraxis Bioscience, Llc Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
WO2009137660A2 (en) * 2008-05-07 2009-11-12 Abraxis Bioscience, Llc Enhancement of drug therapy by mirna
KR101690094B1 (ko) 2008-05-09 2016-12-27 그뤼넨탈 게엠베하 분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 제형을 제조하는 방법
KR20110123252A (ko) * 2009-02-11 2011-11-14 다우 글로벌 테크놀로지스 엘엘씨 연성 중합체 결합제 및 이를 사용하는 배터리 구성요소
US8309356B2 (en) * 2009-04-01 2012-11-13 Yale University Pseudocomplementary oligonucleotides for targeted gene therapy
WO2011009604A1 (en) * 2009-07-22 2011-01-27 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
PE20121067A1 (es) * 2009-07-22 2012-09-05 Gruenenthal Chemie Forma de dosificacion de liberacion controlada extruida por fusion en caliente
EP2287304A1 (en) 2009-08-17 2011-02-23 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Novel treatment of patients after stent implantation or balloon dilatation and novel drug eluting stents
ES2606227T3 (es) 2010-02-03 2017-03-23 Grünenthal GmbH Preparación de una composición farmacéutica en polvo mediante una extrusora
US20110293585A1 (en) 2010-04-21 2011-12-01 Helix Therapeutics, Inc. Compositions and methods for treatment of lysosomal storage disorders
WO2011133803A1 (en) 2010-04-21 2011-10-27 Helix Therapeutics, Inc. Compositions and methods for targeted inactivation of hiv cell surface receptors
WO2012028319A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
CA2808541C (en) 2010-09-02 2019-01-08 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
US8459326B2 (en) * 2011-01-06 2013-06-11 Hunter Douglas, Inc. Cellular shade assembly and method for constructing same
AU2012212105A1 (en) 2011-02-03 2013-09-12 Mirna Therapeutics, Inc. Synthetic mimics of miR-124
RU2615117C2 (ru) 2011-02-03 2017-04-04 Мирна Терапетикс, Инк. ДВУХЦЕПОЧЕЧНАЯ МОЛЕКУЛА РНК ДЛЯ ОБЕСПЕЧЕНИЯ КЛЕТКИ АКТИВНОСТЬЮ miR-34a
JP5927184B2 (ja) * 2011-06-03 2016-06-01 住友精化株式会社 ポリアルキレンオキシド粒子及びその製造方法
WO2012165199A1 (ja) * 2011-06-03 2012-12-06 住友精化株式会社 ポリアルキレンオキシド粒子及びその製造方法
US8759313B2 (en) 2011-08-03 2014-06-24 The Charlotte-Mecklenburg Hospital Authority Treatment of fibrosis using microRNA 19b
KR20140053158A (ko) 2011-07-29 2014-05-07 그뤼넨탈 게엠베하 즉시 약물 방출을 제공하는 탬퍼-저항성 정제
AR087360A1 (es) 2011-07-29 2014-03-19 Gruenenthal Gmbh Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
CA2864949A1 (en) 2012-02-28 2013-09-06 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
JP6282261B2 (ja) 2012-04-18 2018-02-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 不正使用防止および過量放出防止医薬剤形
MX357783B (es) 2012-05-11 2018-07-25 Gruenenthal Gmbh Forma de dosificacion farmaceutica termoconformada, resistente al uso indebido, que contiene zinc.
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
EP2931272A1 (en) 2012-12-12 2015-10-21 The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System Methods of treating hepatic fibrosis and associated diseases by regulating rev-erb activity
US9872851B2 (en) 2012-12-12 2018-01-23 The Charlotte-Mecklenburg Hospital Authority Methods of treating portal hypertension
EP3003279A1 (en) 2013-05-29 2016-04-13 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
CA2913209A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CA2930729A1 (en) 2013-11-22 2015-05-28 Dow Global Technologies Llc Zinc catalyst/additive system for the polymerization of epoxide monomers
JP6122222B2 (ja) * 2013-11-22 2017-04-26 ダウ グローバル テクノロジーズ エルエルシー エポキシドモノマーの重合のための亜鉛触媒／添加剤システム
EP3071626B1 (en) * 2013-11-22 2017-12-20 Dow Global Technologies LLC Zinc catalyst / additive system for the polymerization of epoxide monomers
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
BR112016024265A2 (pt) 2014-04-30 2017-08-15 Dow Global Technologies Llc tratamento de suspensões minerais aquosas com um floculante polimérico
BR112016024409A2 (pt) 2014-04-30 2017-08-15 Dow Global Technologies Llc floculantes poliméricos para tratar suspensões minerais aquosas
EP3140269B1 (en) 2014-05-09 2023-11-29 Yale University Hyperbranched polyglycerol-coated particles and methods of making and using thereof
US11918695B2 (en) 2014-05-09 2024-03-05 Yale University Topical formulation of hyperbranched polymer-coated particles
CA2947786A1 (en) 2014-05-12 2015-11-19 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising tapentadol
WO2015181059A1 (en) 2014-05-26 2015-12-03 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
WO2016019213A1 (en) 2014-07-31 2016-02-04 Dow Global Technologies Llc In-line dynamic mixing apparatus for flocculating and dewatering oil sands fine tailings
JP2018517676A (ja) 2015-04-24 2018-07-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時放出および溶媒抽出に対する耐性を有する改変防止製剤
US10781117B2 (en) 2015-08-25 2020-09-22 Dow Global Technologies Llc Flocculation of high-solids mineral slurries
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
JP2019508037A (ja) 2016-02-16 2019-03-28 イェール ユニバーシティーＹａｌｅ Ｕｎｉｖｅｒｓｉｔ 標的化遺伝子編集を増強するための組成物およびその使用方法
WO2017143061A1 (en) 2016-02-16 2017-08-24 Yale University Compositions and methods for treatment of cystic fibrosis
AR108480A1 (es) 2016-05-27 2018-08-22 Dow Global Technologies Llc Método de tratamiento de suspensiones minerales con alto contenido de sólidos con floculantes poliméricos
WO2017207623A1 (en) 2016-05-31 2017-12-07 Université de Lausanne Mirna as biomarkers and regulators of cancer stem cells
US20190322643A1 (en) 2016-06-29 2019-10-24 Georgia State University Research Foundation, Inc. Histone deacetylase and histone methyltransferase inhibitors and methods of making and use of the same
US20190276345A1 (en) 2016-09-23 2019-09-12 Dow Global Technologies Llc Process for tailings remediation
RU2019109872A (ru) 2016-09-27 2020-10-05 Дау Глоубл Текнолоджиз Ллк Способ обезвоживания водного технологического потока
CA3042016A1 (en) 2016-10-31 2018-05-03 Dow Global Technologies Llc Online analysis of oil sands tailings content
WO2018187493A1 (en) 2017-04-04 2018-10-11 Yale University Compositions and methods for in utero delivery
WO2019075296A1 (en) 2017-10-13 2019-04-18 Dow Global Technologies Llc METHOD FOR IMPROVING THE FLOWABILITY OF QUEUE PRODUCTS FOR PIPELINE TRANSPORT
WO2019154884A1 (en) 2018-02-07 2019-08-15 Ecole Polytechnique Federale De Lausanne (Epfl) Method for determining cancer invasiveness and patient prognosis
CN117925571A (zh) 2018-10-19 2024-04-26 德克萨斯州大学系统董事会 工程化长散在元件（line）转座子及其使用方法
EP3677693A1 (en) 2019-01-03 2020-07-08 Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO Transpochimeric gene trancripts (tcgts) as cancer biomarkers
US20220372474A1 (en) 2019-06-21 2022-11-24 Yale University Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
US20220243211A1 (en) 2019-06-21 2022-08-04 Yale University Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
WO2021022161A1 (en) 2019-07-31 2021-02-04 Yale University Compositions and methods for treating sickle cell disease
WO2022237974A1 (en) 2021-05-12 2022-11-17 Ecole Polytechnique Federale De Lausanne (Epfl) Krab-containing zinc finger protein and cancer
US20240279687A1 (en) 2021-06-07 2024-08-22 Yale University Peptide nucleic acids for spatiotemporal control of crispr-cas binding
JP2023043054A (ja) 2021-09-15 2023-03-28 住友精化株式会社 ポリアルキレンオキシドの製造方法及びポリアルキレンオキシド

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3385800A (en) * 1958-11-24 1968-05-28 Gen Tire & Rubber Co Polymerization of alkylene oxides by a catalyst system comprising organometallic compounds in combination with an oxygen-containing cocatalyst
GB980615A (en) * 1961-03-14 1965-01-13 Takeda Chemical Industries Ltd A catalytic method for preparing alkyleneoxide polymers
US3639267A (en) * 1969-12-19 1972-02-01 Hercules Inc Organozinc catalyst composition
JPS5035538B2 (pt) * 1972-06-29 1975-11-17
JPS5831055B2 (ja) * 1976-08-26 1983-07-04 松下電器産業株式会社 テレビジヨン受像機のプログラム制御装置

Also Published As

Publication number Publication date
EP0243969A3 (en) 1988-10-05
CA1279435C (en) 1991-01-22
JPH0474370B2 (pt) 1992-11-26
AU7227387A (en) 1987-11-05
JPS62273227A (ja) 1987-11-27
EP0243969A2 (en) 1987-11-04
US4667013A (en) 1987-05-19

Similar Documents

Publication Publication Date Title
BR8702151A (pt) Processo de controle do peso molecular de oxidos polialquenicos
PT83608B (pt) Processo de preparacao de derivados da paroxetina
PT83643B (pt) Processo de preparacao de derivados de quinoleina
BR8702091A (pt) Sistema de controle de mudanca
BR8602293A (pt) Processo catalitico de preparacao 1,4-cispolibutadieno
DK166866C (da) Passagerbro til fly
PT90637A (pt) Processo de preparacao de polianidridos
PT89946A (pt) Processo de preparacao de sulfatos ciclicos
BR8603413A (pt) Sistema de controle de maquina e processo para operar maquina
BR8607194A (pt) Processo de preparacao de materiais de construcao
BG80504A (bg) Функционален блок на днк
BR8601229A (pt) Processo de preparacao de poliisocianatos poliisocianuratos por ciclotrimerisacao catalitica de poliisocianatos
BR8802937A (pt) Derivados de 4-nitro-n-fenil-pirazol,processo,composicao e controle de pragas
BR9004365A (pt) Aperfeicoamento relacionados ao controle de cupins
BR8707666A (pt) Processo catalisado com acido
PT86069A (pt) Processo de preparacao de ureia
BR8701990A (pt) Circuito de controle
PT89578A (pt) Processo de preparacao de acido n-fosfono-metil-imino-diacetico
PT84014B (pt) Processo de preparacao de aminoetil-indoles e de medicamentos contendo-os
PT84624B (pt) Processo de preparacao de imidazois substituidos
PT84553B (pt) Processo de preparacao de derivados de indenopirimidina
BR8601349A (pt) Processo de preparar w-lactamas
DK292387D0 (da) Forherd
BR8605122A (pt) Processo e aparelhagem de controle de carga
BR8601135A (pt) Processo de preparacao de acetais dialquilicos de alcanais ou de arilalcanais